AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
BEDAQUILINE in Zimbabwe
4 products registered with MCAZ — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| RESILIN TABLET; ORAL | 2025/7.3/7087 | MSN LABORATORIES PRIVATE LIMITED | active | 7 Oct 2030 |
| NONE TABLET; ORAL | 2025/7.3/7074 | MACLEODS PHARMACEUTICALS LIMITED | active | 24 Sept 2030 |
| SIRTURO TABLET; ORAL | 2021/7.3/6156 | JANSSEN-CILAG INTERNATIONAL NV | active | 31 Dec 2027 |
| BEDAQUILINE TABLET, COATED; ORAL | 2024/7.3/6712 | LUPIN LIMITED | active | 31 Dec 2027 |
BEDAQUILINE — MCAZ Registration Details
MCAZ (Zimbabwe) has 4 registered products containing BEDAQUILINE, of which 4 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track BEDAQUILINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.